-

Live Pharmacy Next expert panel predicts future of medication safety, affordability, & personalization

November 3rd online event, hosted by Wolters Kluwer, features industry experts from Brigham and Women’s Hospital in Boston, CVS Caremark, and the University of Kentucky School of Pharmacy

--(BUSINESS WIRE)--Wolters Kluwer (AEX:WKL):

What: Pharmacy Next: Safer, Affordable & Personalized, a Wolters Kluwer-hosted online panel of medical, retail pharmacy, and pharmacogenomics experts predicting the future of prescription medications and pharmacy as healthcare delivery decentralizes across the care continuum.

The panel will discuss what patient safety risks are emerging with prescription medicines in tomorrow’s more distributed care models, whether patient trust and outcomes will improve as prescribing roles evolve, and how health consumers’ medication costs can be contained. Plus, as innovative precision medicines spread, are Americans open to pharmacogenomic testing to match them with treatments more uniquely personalized to their individual genetics?

Pharmacy Next panelists will also discuss surprising results from a new Wolters Kluwer consumer survey that foreshadows massive shifts in who Americans trust for medication prescribing, worries, as well as the trade-offs consumers are willing to accept for lower drug costs.

When: Thursday, November 3, 2022, at 11 a.m. EDT

Where: This is a live online event with attendee Q&A. Registration is free and can be accessed here. Attendees who join the live event will be the first to receive an executive summary of the new Pharmacy Next consumer survey followed by an in-depth report in January 2023.

Who: Peter Bonis, MD, Chief Medical Officer at Wolters Kluwer, will introduce the Pharmacy Next panel. Daniel Streetman, PharmD, of the Metabolism, Interactions, and Genomics group at Wolters Kluwer, will moderate the discussion.

Pharmacy Next panelists include:

  • David Bates, MD, an internationally renowned expert on patient safety from Brigham and Women’s Hospital and Harvard Medical School
  • Daniel Knecht, MD, VP and Chief Clinical Innovation Officer at CVS Caremark
  • Jill Kolesar, PharmD, an expert in pharmacy practice and precision medicine from the University of Kentucky School of Pharmacy

Register to attend the live Pharmacy Next panel here.

About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Contacts

Media
André Rebelo
Public Affairs & Public Relations Associate Director
Wolters Kluwer
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

Wolters Kluwer Health

AEX:WKL
Details
Headquarters: Alphen aan den Rijn, Netherlands
CEO: Nancy McKinstry
Employees: 21600
Organization: PUB
Revenues: €5,916 million (2024)

Release Versions

Contacts

Media
André Rebelo
Public Affairs & Public Relations Associate Director
Wolters Kluwer
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

More News From Wolters Kluwer Health

Wolters Kluwer Experts Forecast Deeper Healthcare AI Penetration in 2026, Enabled by Momentum in Workflow Integration and Governance

WALTHAM, Mass.--(BUSINESS WIRE)--With 2026 fast approaching, the healthcare sector is poised for the next stage of gains in AI adoption. Predictions point to increasingly strategic implementation of productivity enablers as well as advancements in clinical decision making technology that connect clinicians with better answers to care for their patients. To highlight what obstacles and opportunities in healthcare technology lie ahead in 2026, leading experts from Wolters Kluwer Health share thei...

Wolters Kluwer Future Ready Healthcare Survey Report Reveals Significant Opportunity for Healthcare GenAI—If Health Systems Can Overcome the Readiness Gap

WALTHAM, Mass.--(BUSINESS WIRE)--The 2025 Future Ready Healthcare Survey Report finds GenAI is top of mind for many health professionals but most organizations aren't ready to adopt....

Wolters Kluwer Launches Lippincott Nursing Advisory Board to Elevate Clinical Excellence in India

NEW DELHI--(BUSINESS WIRE)--Wolters Kluwer is proud to announce the launch of the Lippincott Nursing Advisory Board, a groundbreaking initiative committed to advancing nursing excellence, standardizing care, and enhancing patient outcomes through evidence-based knowledge and clinical decision support. Launched today at ANEICON, the largest nursing conference in India, this Advisory Board is driven by a commitment to continuous professional development and the 'Make it Better' mission of Wolters...
Back to Newsroom